Clinical Trial Update: Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rosiglitazone in nondiabetic patients with metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Metabolic Syndrome

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Metabolic Syndrome, Insulin Resistance | Phase 4 | Status: COMPLETED